Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Press Release: Senator Hassan's Investigation Leads to Generic Inhaler Availability for Children Following Big Pharma Price Hike Practices

None

Senator Hassan's investigation prompts a pharmaceutical company to reduce inhaler prices, enabling affordable access for children with asthma.

Quiver AI Summary

Senator Hassan announces pharmaceutical breakthrough: Senator Maggie Hassan has announced that following her investigation, GlaxoSmithKline (GSK) has ended its monopoly on the Flovent asthma inhaler. This change will enable a lower-cost generic version to be introduced to the market, benefiting millions of children with asthma who require affordable medication.

Details of the investigation: The senator's report condemns GSK's previous pricing practices, which she claims caused significant hardship for families reliant on the inhaler. The new generic inhaler, approved by the FDA just prior to the report's release, aims to alleviate the financial burden on families facing high medication costs.

Call for further action: Senator Hassan emphasized the need for Congress to address loopholes that allowed GSK to raise prices and maintain its monopoly, stating that the goal is to prevent other pharmaceutical companies from implementing similar strategies that compromise patient care.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

🏛️ Receive Alerts on Congress
Sign Up

Margaret Wood Hassan Fundraising

Margaret Wood Hassan Fundraising

Margaret Wood Hassan recently disclosed $360.8K of fundraising in a Q4 FEC disclosure filed on January 30th, 2026. This was the 266th most from all Q4 reports we have seen this year. 79.2% came from individual donors.

Hassan disclosed $252.3K of spending. This was the 290th most from all Q4 reports we have seen from politicians so far this year.

Hassan disclosed $1.4M of cash on hand at the end of the filing period. This was the 291st most from all Q4 reports we have seen this year.

You can see the disclosure here, or track Margaret Wood Hassan's fundraising on Quiver Quantitative.

Margaret Wood Hassan Net Worth

Quiver Quantitative estimates that Margaret Wood Hassan is worth $6.0M, as of March 16th, 2026. This is the 155th highest net worth in Congress, per our live estimates.

Hassan has approximately $3.8M invested in publicly traded assets which Quiver is able to track live.

You can track Margaret Wood Hassan's net worth on Quiver Quantitative's politician page for Hassan.

Margaret Wood Hassan Bill Proposals

Here are some bills which have recently been proposed by Margaret Wood Hassan:

  • S.4071: A bill to amend the Internal Revenue Code of 1986 to create a Business Child Care Liaison within the Internal Revenue Service.
  • S.3962: A bill to improve interagency coordination between the Department of Housing and Urban Development and the Economic Development Administration, and for other purposes.
  • S.3714: Family-to-Family Reauthorization Act of 2026
  • S.3596: Stronger Start for Working Families Act
  • S.3560: Closing the Contraception Coverage Gap Act
  • S.3522: No Red Tape For Addiction Treatment Act

You can track bills proposed by Margaret Wood Hassan on Quiver Quantitative's politician page for Hassan.

2028 New Hampshire US Senate Election

There has been approximately $16,256,329 of spending in New Hampshire US Senate elections over the last two years, per our estimates.

Approximately $534,704 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

The rating for this race is currently "Lean D".

You can track this election on our matchup page for the 2028 New Hampshire US Senate election.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles